CoviDx™ SARS-CoV-2 Rapid Antigen Test is a lateral flow assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs and nasopharyngeal swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first 5 days of symptoms.1

Benefits of using CoviDx:

  • Results within 20 minutes: facilitate immediate patient isolation
  • Flexible workflow: pre-filled extraction vials and individually packaged reagents enable multiple independent workstations for increased test distribution
  • Easy-to-use: instrument-free, user-friendly test procedure for non-lab settings
  • Convenient: all materials included in the kit for hassle-free logistics
  • Accurate: 100% Positive Percent Agreement (PPA) with PCR for samples with Ct values ≤ 301